CTOs on the Move

Flybridge Capital Partners

www.flybridge.com

 
Flybridge Capital is a Boston-based venture capital firm that invests in early-stage technology companies. Themes and sectors the firm is currently focused on include consumer infrastructure, enterprise IT, online advertising optimization, Big Data, energy efficiency, dynamic computing architectures and financial tech.    Flybridge is typically the first institutional investor in the companies it backs. The firm focuses on investing in capital efficient businesses seeking capital to fuel growth and expand operations. With a core focus on early-stage and seed investing, the firm works with companies in a range of phases in the investment cycle. The firm’s initial investment sizes range from sub ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.flybridge.com
  • 500 Boylston Street 18th Floor
    Boston, MA USA 02116
  • Phone: 617.307.9292

Executives

Name Title Contact Details

Similar Companies

Global Securities Inc

Global Securities Inc is a Arcadia, CA-based company in the Financial Services sector.

Xpress Holdings

Xpress Holdings LLC is a San Juan Capistrano, CA-based company in the Financial Services sector.

Invictus Md

Invictus MD Strategies Corp., Canada`s Cannabis Company, is focused on two main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR and Fertilizer and Nutrients through Future Harvest Development Ltd. Invictus is publicly traded on the TSX Venture Exchange under the ticker symbol "GENE" as well as "8IS1" in Frankfurt and "IVITF" on the OTCQX.

Santa Fe Capitol Group

Santa Fe Capitol Group is a Santa Fe, NM-based company in the Financial Services sector.

Omega Fund

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world`s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised more than $1 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA.